As deadly ‘superbugs’ outsmart antibiotics, a Penn scientist uses artificial intelligence to design new ones

  04 November 2019

In his lab at the University of Pennsylvania, de la Fuente and his team use computer algorithms to design and refine new drugs, sifting through chemical building blocks for combinations that are predicted to penetrate bacterial defenses.

Further reading: The Philadelphia Inquirer
Author(s): Tom Avril
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!